Description
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
| Purity | ≥95% |
|---|---|
| Formula | C138H230N46O34S4 |
| Formula Wt. | 3205.89 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hongbiao W, Baolong N, Mengkui X, et al. Biological activities of cecropin B-thanatin hybrid peptides. J Pept Res. 2005 Dec;66(6):382-6. PMID: 16316454.
PDE3/5 inhibitor, LTD4 antagonist.
Casein kinase 1 inhibitor.
Histamine H2 antagonist, GSK-3β inhibitor.
Benzimidazole; microtubule polymerization inhib...
Phenylpyrazoleanilide; IL-17 production inhibit...
CDK2/4/6 inhibitor
Peptide, involved in synapse formation and cell...
CDK4/6 inhibitor.
Pyridopyrimidinone; PI3K and mTOR inhibitor.
HDAC1/2/3/11 inhibitor.
MEK inhibitor.
Non-nitrogen bisphosphonate; mitochondrial ATP/...
5-FU prodrug; thymidylate synthase inhibitor.
Potential voltage-gated Na+ channel blocker.
GHS-R1a agonist, γ-secretase inhibitor.
Glycosylated isoflavone found in soy; TAS2R ago...
Endogenous peptide hormone fragment, involved i...
Vitamin A derivative; RAR and RXR agonist.
CRM1/XPO1 inhibitor.
Inhibitor of Bcl-2 and Bcl-xL